BERDAOUI
ActiveSummary
BERDAOUI has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €200,497 and a net result of €75,867. Its solvency ranks better than 24% of 19922 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability86▼-14
Solvency61▼-38
Growth52
Track record94
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €14,000 at 30 days acceptable
Liquidity ample (current ratio 2.76 against 3.91 in 2023; short-term debt: 13.5% and cash: 2.4% of total assets), but 64.2% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 24% of 19922 sector peers (2024).
NBB · sector comparisonPosition among 19922 sector peers
Solvency
better than 24%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-06-2026, 46 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
46 d early
2024
26 d late
2023
31 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 3 accounts on average 17 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 1 July (3 of the last 3 filed years within 56 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema
Equity
€200,497▲ 60.9%
2023 · €124,630
Total assets
€560,155▲ 235%
2023 · €167,444
Net result
€75,867▼ 37.6%
2023 · €121,630
Working capital
€133,005▲ 6.7%
2023 · €124,630
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20232024
Operating result€154,572-€93,464▼ 39.5%
Net result€121,630above the sector's middle half-€75,867within the sector's middle half▼ 37.6%
Equity€124,630within the sector's middle half-€200,497within the sector's middle half▲ 60.9%
Total assets€167,444within the sector's middle half-€560,155within the sector's middle half▲ 235%
Debt€42,814-€359,658▲ 740%
Working capital€124,630within the sector's middle half-€133,005within the sector's middle half▲ 6.7%
Solvency74.4%within the sector's middle half-35.8%below the sector's middle half▼ 38.6pp
Current ratio3.91within the sector's middle half-2.76within the sector's middle half▼ 1.15
Return on assets (ROA)72.6%above the sector's middle half-13.5%within the sector's middle half▼ 59.1pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 40% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €560,155
Fixed assets
€351,790
Current assets
€208,365
Equity and liabilities €560,155
Equity
€200,497 ▲ 60.9%
Debt
€359,658 ▲ 740%
Debt's share of the balance-sheet total rises from 25.6% to 64.2%. Equity and debt are higher.
Key figures and ratios
EBITDA
€94,174
Cash flow
€76,577
Debt to equity
1.79▲
2023 · 0.34
ROE
37.8%▼
2023 · 97.6%
Interest coverage
28.81
Debt ≤ 1 year
€75,361▲
2023 · €42,814
Debt > 1 year
€284,297
Income taxes
€19,726▼
2023 · €34,314
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2023 | 2024 | Change |
|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | - | €710 | - |
| Other operating charges640/8 | €384 | €387 | ▲ 0.8% |
| Gross operating margin9900 | €154,956 | €94,562 | ▼ 39.0% |
| Operating profit (loss)9901 | €154,572 | €93,464 | ▼ 39.5% |
| Financial income75/76B | €1,501 | €5,398 | ▲ 260% |
| Recurring financial income75 | €1,501 | €5,398 | ▲ 260% |
| Financial charges65/66B | €128 | €3,269 | ▲ 2,449% |
| Recurring financial charges65 | €128 | €3,269 | ▲ 2,449% |
| Profit (loss) for the period before taxes9903 | €155,944 | €95,593 | ▼ 38.7% |
| Income taxes67/77 | €34,314 | €19,726 | ▼ 42.5% |
| Profit (loss) for the period9904 | €121,630 | €75,867 | ▼ 37.6% |
| Profit (loss) for the period to be appropriated9905 | €121,630 | €75,867 | ▼ 37.6% |
| Line | 2023 | 2024 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €167,444 | €560,155 | ▲ 235% |
| Fixed assets21/28 | - | €351,790 | - |
| Tangible fixed assets22/27 | - | €1,790 | - |
| Furniture and vehicles24 | - | €1,790 | - |
| Financial fixed assets28 | - | €350,000 | - |
| Current assets29/58 | €167,444 | €208,365 | ▲ 24.4% |
| Amounts receivable within one year40/41 | €132,493 | €194,357 | ▲ 46.7% |
| Trade receivables40 | €75,735 | €73,598 | ▼ 2.8% |
| Other amounts receivable41 | €56,758 | €120,759 | ▲ 113% |
| Cash at bank and in hand54/58 | €34,951 | €13,601 | ▼ 61.1% |
| Deferred charges and accrued income490/1 | - | €407 | - |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €167,444 | €560,155 | ▲ 235% |
| Equity10/15 | €124,630 | €200,497 | ▲ 60.9% |
| Contributions10/11 | €3,000 | €3,000 | = |
| Profit (loss) carried forward14 | €121,630 | €197,497 | ▲ 62.4% |
| Amounts payable17/49 | €42,814 | €359,658 | ▲ 740% |
| Amounts payable after more than one year17 | - | €284,297 | - |
| Financial debts170/4 | - | €284,297 | - |
| Amounts payable within one year42/48 | €42,814 | €75,361 | ▲ 76.0% |
| Current portion of amounts payable after more than one year42 | - | €35,178 | - |
| Trade debts44 | - | €2,143 | - |
| Suppliers440/4 | - | €2,143 | - |
| Taxes, remuneration and social security45 | €42,814 | €38,040 | ▼ 11.2% |
| Taxes450/3 | €42,814 | €38,040 | ▼ 11.2% |
| Line | 2023 | 2024 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €121,630 | €75,867 | ▼ 37.6% |
| + Depreciation and write-downs630 | - | €710 | - |
| Operating cash flow (approximation) | €121,630 | €76,577 | ▼ 37.0% |
| Change in cash | - | -€21,350 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
15-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
26-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 26 days late
2024
31-12
Financial
Equity above €200,000Eq €200,497 ▲60.9%
2 profitable years in a row build equity to €200,497.
30-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brussel · 1 establishment unit since 2023
Ground area
605 m²
Building footprint
210 m²
Volume, LiDAR
1,944 m³
Parcel 21816G0043/00T006, Brussels · tallest building 11.8 m, ±3 floors. Linked by address, not a title deed.
4
companies at this address
See who is registered here
1 establishment unit
BERDAOUI
since 20232.341.945.333
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21816G0043/00T006 | Brussels | 605 m² | 1 · 209 m² | 11.8 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 holdingOwners 0
The accounts to 31-12-2024 list no shareholders, and no other source names one.
Holdings 1
-
100%
According to the 2024 annual accounts of BERDAOUI and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector, comparable size
VFC Medical Imaging
BE 1011.198.373
Gesves · Eq €200,493
KANDIL HEALTH
BE 0810.308.108
Wavre · Eq €200,371
DEVIDERMA
BE 0810.861.503
Asse · Eq €200,775
FOSTIER ANESTHESIE
BE 0754.904.181
Jemeppe-sur-Sambre · Eq €200,163
Dr Karina PHILIPS , Dermatologie
BE 0834.676.684
Steenokkerzeel · Eq €200,989
Of 16,629 companies in sector 86220 we hold annual accounts for 7,986. 6,743 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded16-02-2023
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0798551015
Registered
23-02-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.